The Current Ratio as of November 2024 (TTM) for Conformis, Inc. (CFMS) is 5.07

According to Conformis, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.07. This represents a change of -5.59% compared to the average of 5.37 of the last 4 quarters.

Conformis, Inc. (CFMS) Historical Current Ratio (quarterly & annually)

How has CFMS Current Ratio performed in the past?

The mean historical Current Ratio of Conformis, Inc. over the last ten years is 5.50. The current 5.07 Current Ratio has changed 9.12% with respect to the historical average. Over the past ten years (40 quarters), CFMS's Current Ratio was at its highest in in the September 2015 quarter at 11.96. The Current Ratio was at its lowest in in the March 2014 quarter at 0.

Conformis, Inc. (CFMS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Conformis, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Conformis, Inc. (CFMS) Average Current Ratio

How has CFMS Current Ratio performed in the past?

The current Current Ratio of Conformis, Inc. (CFMS) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Conformis, Inc. (CFMS) Current Ratio vs. Peers

How is CFMS’s Current Ratio compared to its peers?

Conformis, Inc.’s Current Ratio is less than Bone Biologics Corporation (11.22), less than Tivic Health Systems, Inc. (7.89), greater than Bluejay Diagnostics, Inc. (4.38), greater than Vivos Therapeutics, Inc. (1.18), less than Rapid Micro Biosystems, Inc. (5.52), greater than Artivion, Inc. (4.63), less than Anika Therapeutics, Inc. (5.34), less than Sight Sciences, Inc. (11.01), greater than Orthofix Medical Inc. (2.48), greater than Avanos Medical, Inc. (2.22), less than CVRx, Inc. (11.32), greater than Accelerate Diagnostics, Inc. (1.28), less than NeuroPace, Inc. (6.37), greater than AxoGen, Inc. (3.51), less than Talis Biomedical Corporation (7.76), greater than Nuwellis, Inc. (1.20), greater than Heart Test Laboratories, Inc. (4.49), greater than PAVmed Inc. (0.57), greater than ProSomnus, Inc. Common Stock (0.30), less than Hyperfine, Inc. (8.08), greater than OrthoPediatrics Corp. (4.90),

Build a custom stock screener for Conformis, Inc. (CFMS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Conformis, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Conformis, Inc. (CFMS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Conformis, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.